Cargando…
Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation
BACKGROUND: Neurologic toxicities with immune therapy are rare, but can cause devastating and often permanent injury when they occur. Although there is increasing interest in the potential synergism between immune therapy and radiation, it is possible that such combinations may lead to a greater num...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303890/ https://www.ncbi.nlm.nih.gov/pubmed/30577851 http://dx.doi.org/10.1186/s40425-018-0471-2 |